Blood test may predict lung cancer recurrence
NCT ID NCT07186855
First seen Oct 31, 2025 · Last updated May 21, 2026 · Updated 34 times
Summary
This study looked at 500 people with non-small cell lung cancer who had surgery. Researchers used a blood test to find circulating tumor cells (CTCs) and checked if the number or type of these cells could predict whether the cancer would come back. The goal was to learn how well CTC monitoring works for forecasting recurrence, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nationa Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijingn, 100021, China
Conditions
Explore the condition pages connected to this study.